EUVIMEDEUVIMED entdecken
Crossref

Liver Biopsy: To Do or Not to Do – A Single-Center Study

Theodoros Androutsakos, Konstantinos Dimitriadis, Konstantinos Revenas, Chrysovalantis Vergadis, Dimitrios-Dorotheos Papadakis, Stratigoula Sakellariou, Christos Vallilas, Gregorios Hatzis

Digestive Diseases · 2023

DOI: 10.1159/000533328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases, 2023. Verfasst von Theodoros Androutsakos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathophysiology Department, National and Kapodistrian University of Athens, Medical School, Athens, Greece. Hauptthemen laut MEDLINE: Liver Diseases, Digestive System Surgical Procedures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A variety of liver disorders are associated with characteristic histopathological findings that help in their diagnosis and treatment. However, percutaneous liver biopsy (PLB) is prone to limitations and complications. We evaluated all PLBs done in our hospital in a 13-year period, aiming to assess PLB’s utility and complications.

Methods

All PLBs conducted in an internal medicine department of a tertiary university hospital in Athens, Greece, during a 13-year period were reviewed. Recorded data included demographic characteristics, laboratory results acquired on biopsy day, indication for liver biopsy, and occurrence of side effects. All patients were followed for 1 month post-hospital discharge for possible PLB-related complications.

Results

A total of 261 patients underwent PLB during the study period. The commonest indication of PLB was investigation of liver mass, followed by transaminasemia. PLB assisted in setting a diagnosis in 218 patients and was unhelpful in only 43, in 14 of them due to inadequate or inappropriate biopsy specimen. Complications attributable to PLB were rare, with 10 patients exhibiting pain, either at biopsy site or in the right shoulder, and 3 having bleeding episodes; no deaths were noted.

Conclusions

Our study shows that PLB is still a powerful diagnostic tool in everyday practice, provided it is used when indicated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesDigestive System Surgical ProceduresHumansLiverBiopsyBiopsy, Needle

Stichwörter der Autor:innen

CholestasisLiverLiver biopsyLiver massTransaminasemia

Autor:innen und Institutionen

  • Pathophysiology Department, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Radiology Department, Laiko University Hospital, Athens, Greece.
  • 1st Department of Pathology, National and Kapodistrian University of Athens, Medical School, Athens, Greece.

Zitieren

APA

Androutsakos, T., Dimitriadis, K., Revenas, K., Vergadis, C., Papadakis, D. D., Sakellariou, S., Vallilas, C., & Hatzis, G. (2023). Liver Biopsy: To Do or Not to Do – A Single-Center Study. Digestive Diseases. https://doi.org/10.1159/000533328

Vancouver

Androutsakos T, Dimitriadis K, Revenas K, Vergadis C, Papadakis DD, Sakellariou S, et al. Liver Biopsy: To Do or Not to Do – A Single-Center Study. Digestive Diseases. 2023. doi:10.1159/000533328

BibTeX
@article{Androutsakos2023,
  author = {Androutsakos, Theodoros and Dimitriadis, Konstantinos and Revenas, Konstantinos and Vergadis, Chrysovalantis and Papadakis, Dimitrios-Dorotheos and Sakellariou, Stratigoula and Vallilas, Christos and Hatzis, Gregorios},
  title = {Liver Biopsy: To Do or Not to Do – A Single-Center Study},
  journal = {Digestive Diseases},
  year = {2023},
  doi = {10.1159/000533328}
}
Kostenlos starten →